Document is current
Any future updates will be listed below
-
Authors
Lee, Chae-Jeong https://orcid.org/0009-0000-3963-8464
Jang, Seung Hyun
Lim, Jiwoo
Park, Hyunju
Ahn, So-Hee
Park, Seon Young
Seo, Hyangmi
Song, Soo-Jin https://orcid.org/0009-0004-8955-1980
Shin, Jung-A
Choi, Chulhee https://orcid.org/0000-0001-5542-9136
Gee, Heon Yung https://orcid.org/0000-0002-8741-6177
Choi, Youn-Hee
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2020R1A5A2019210, 2018R1A5A2025079)
Korea Health Industry Development Institute (HI21C187101)
- License Information
-
More Information
Article History
Received: 16 August 2024
Revised: 25 October 2024
Accepted: 29 October 2024
First Online: 20 January 2025
Competing interests
: C.C. is the founder and shareholder of ILIAS Biologics, Inc. The remaining authors declare no competing interests.
